Using A20 cells, additive control of tumor growth was observed when mouse (m) SIRP-α-Fc-CD40L was combined with anti-CD20 antibodies as compared with anti-CD20 antibodies alone or mSIRPα-Fc-CD40L alone. Here, SIRPA is linked to neoplasm.